FigureĀ 1.
Kaplan-Meier curves of efficacy outcomes. Kaplan-Meier curves by IRC assessment for PFS (A), OS (B), DOR (C), and DOCR (D) in the overall population and by pLOT. PFS was defined as time from cycle 1 day 1 to first documented progression or death due to any cause. OS was defined as time from cycle 1 day 1 to death due to any cause. A sensitivity analysis for OS censored patients at the date of last disease assessment before death due to confirmed COVID-19. DOR was defined as time from first CR or PR to first documented progression or death due to any cause. DOCR was defined as time from first CR to first documented progression or death due to any cause.